STOCK TITAN

CBD Life Sciences, Inc. (CBDL) Unveils Mellow Mornings: A Revolutionary Nano CBD Coffee Creamer Set to Boost Revenue Amid Growing National Demand

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

CBD Life Sciences, Inc. (OTC PINK:CBDL) has launched Mellow Mornings, a nano CBD Coffee Creamer, targeting the rapidly growing CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla, and Classic flavors, each bottle contains 1000mg of CBD. The company projects this product could add up to $2 million in annual revenue within its first year. Utilizing nanotechnology, Mellow Mornings offers superior bioavailability, making it up to 10 times more effective than traditional formulations. The CBD-infused beverage market is expected to reach $2.6 billion by 2025. Local coffee shops are already adopting Mellow Mornings for specialty CBD Lattes, indicating strong market potential.

CBD Life Sciences, Inc. (OTC PINK:CBDL) ha lanciato Mellow Mornings, un crema da caffè al nano CBD, mirato al mercato del caffè CBD in rapida crescita. Disponibile in flavor Pumpkin Spice Cheesecake, Pumpkin, Vanilla e Classic, ogni bottiglia contiene 1000mg di CBD. L'azienda prevede che questo prodotto possa generare fino a 2 milioni di dollari di fatturato annuale nel suo primo anno. Utilizzando la nanotecnologia, Mellow Mornings offre una superiore biodisponibilità, rendendolo fino a 10 volte più efficace rispetto alle formulazioni tradizionali. Si prevede che il mercato delle bevande infuse di CBD raggiunga 2.6 miliardi di dollari entro il 2025. I caffè locali stanno già adottando Mellow Mornings per i loro specialty CBD Lattes, indicando un forte potenziale di mercato.

CBD Life Sciences, Inc. (OTC PINK:CBDL) ha lanzado Mellow Mornings, un crema de café con nano CBD, dirigido al creciente mercado del café con CBD. Disponible en sabor Pumpkin Spice Cheesecake, Pumpkin, Vanilla y Classic, cada botella contiene 1000mg de CBD. La empresa proyecta que este producto podría añadir hasta 2 millones de dólares en ingresos anuales en su primer año. Utilizando nanotecnología, Mellow Mornings ofrece una biodisponibilidad superior, lo que lo hace hasta 10 veces más efectivo que las formulaciones tradicionales. Se espera que el mercado de bebidas infundidas con CBD alcance 2.6 mil millones de dólares para 2025. Las cafeterías locales ya están adoptando Mellow Mornings para sus CBD Lattes especiales, indicando un sólido potencial de mercado.

CBD Life Sciences, Inc. (OTC PINK:CBDL)는 빠르게 성장하는 CBD 커피 시장을 겨냥한 Mellow Mornings, 나노 CBD 커피 크리머를 출시했습니다. 호박 스파이스 치즈케이크, 호박, 바닐라, 클래식 맛으로 제공되며, 각 병에는 1000mg의 CBD가 포함되어 있습니다. 이 회사는 이 제품이 첫 해에 200만 달러의 연 매출을 추가할 수 있을 것으로 예상하고 있습니다. 나노 기술을 이용하여 Mellow Mornings는 우수한 생체이용률을 제공하여 전통적인 제형보다 최대 10배 더 효과적입니다. CBD 주입 음료 시장은 2025년까지 26억 달러에 이를 것으로 예상됩니다. 지역 커피숍은 이미 특수 CBD 라떼를 위해 Mellow Mornings를 채택하고 있으며, 이는 강력한 시장 잠재력을 나타냅니다.

CBD Life Sciences, Inc. (OTC PINK:CBDL) a lancé Mellow Mornings, un crémeux de café nano CBD, visant le marché du café CBD en rapide expansion. Disponible en saveurs Cheesecake au potiron, Potiron, Vanille et Classique, chaque bouteille contient 1000mg de CBD. L'entreprise prévoit que ce produit pourrait ajouter jusqu'à 2 millions de dollars de revenus annuels au cours de sa première année. En utilisant la nanotechnologie, Mellow Mornings offre une bio-disponibilité supérieure, le rendant jusqu'à 10 fois plus efficace que les formulations traditionnelles. Le marché des boissons infusées au CBD devrait atteindre 2,6 milliards de dollars d'ici 2025. Les cafés locaux adoptent déjà Mellow Mornings pour leurs latte CBD spéciaux, indiquant un fort potentiel de marché.

CBD Life Sciences, Inc. (OTC PINK:CBDL) hat Mellow Mornings, eine Nano-CBD-Kaffeetechnologie, auf den Markt gebracht, die auf den schnell wachsenden CBD-Kaffeemarkt abzielt. Erhältlich in Kürbisgewürz-Käsekuchen, Kürbis, Vanille und Klassik-Geschmäckern, enthält jede Flasche 1000mg CBD. Das Unternehmen projiziert, dass dieses Produkt im ersten Jahr bis zu 2 Millionen Dollar Jahresumsatz beitragen könnte. Durch die Nutzung von Nanotechnologie bietet Mellow Mornings eine überlegene Bioverfügbarkeit und ist bis zu 10 Mal effektiver als traditionelle Formulierungen. Der Markt für CBD-infundierte Getränke wird voraussichtlich 2,6 Milliarden Dollar bis 2025 erreichen. Lokale Cafés übernehmen bereits Mellow Mornings für spezielle CBD-Lattes, was auf ein starkes Marktpotenzial hinweist.

Positive
  • Launch of innovative nano CBD Coffee Creamer 'Mellow Mornings'
  • Projected $2 million annual revenue within first year of launch
  • Superior bioavailability due to nanotechnology, up to 10 times more effective
  • Early adoption by local coffee shops for specialty CBD beverages
  • Targeting rapidly growing CBD coffee market, expected to reach $2.6 billion by 2025
Negative
  • None.

SCOTTSDALE, AZ / ACCESSWIRE / September 4, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in the CBD industry, is excited to announce the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to your daily coffee routine.

Riding the Wave of a Growing Market

The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD.

Significant Revenue Potential

Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences, Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country.

Revolutionary CBD Delivery for Maximum Efficacy

Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market.

Adoption by Local Coffee Shops

Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.

A Commitment to Innovation and Quality

"At CBD Life Sciences, Inc., we are continuously innovating to meet the evolving needs of our customers," said Lisa Nelson, President and CEO of CBD Life Sciences, Inc. "Mellow Mornings is more than just a coffee creamer; it's a product that enhances both the flavor and the wellness benefits of coffee, meeting the growing demand for functional beverages."

About CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based & organic products including, Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, Roll-on's, Salve, Full Pet Line, Pre-Rolls, Full Line of Spa Products, Sleep & Anxiety Edibles. The CBD Vault's products can be viewed and purchased on the Company's website www.thecbdvault.com.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC

Instagram: https://www.instagram.com/cbd.vault

IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information

Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

Contact Information

Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.



View the original press release on accesswire.com

FAQ

What is the new product launched by CBD Life Sciences (CBDL)?

CBD Life Sciences (CBDL) has launched Mellow Mornings, a nano CBD Coffee Creamer available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla, and Classic flavors.

How much CBD does each bottle of Mellow Mornings contain?

Each bottle of Mellow Mornings contains 1000mg of CBD.

What is the projected annual revenue for Mellow Mornings by CBD Life Sciences (CBDL)?

CBD Life Sciences (CBDL) projects that Mellow Mornings could add up to $2 million in annual revenue within its first year of launch.

What technology does Mellow Mornings use for CBD delivery?

Mellow Mornings uses nanotechnology for CBD delivery, offering superior bioavailability and making it up to 10 times more effective than traditional formulations.

What is the projected market size for CBD-infused beverages by 2025?

Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025.

CBD LIFE SCIENCES INC

OTC:CBDL

CBDL Rankings

CBDL Latest News

CBDL Stock Data

1.39M
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Scottsdale